Low-dose second-generation oral contraceptives are associated with the lowest increased risk of cardiovascular adverse effects

Research output: Contribution to journal › Comment/debate › Research › peer-review

Standard

Low-dose second-generation oral contraceptives are associated with the lowest increased risk of cardiovascular adverse effects. / Løkkegaard, Ellen.

In: BMJ Evidence-Based Medicine, Vol. 21, No. 6, 232, 12.2016.

Research output: Contribution to journal › Comment/debate › Research › peer-review

Harvard

Løkkegaard, E 2016, 'Low-dose second-generation oral contraceptives are associated with the lowest increased risk of cardiovascular adverse effects', BMJ Evidence-Based Medicine, vol. 21, no. 6, 232. https://doi.org/10.1136/ebmed-2016-110500

APA

Løkkegaard, E. (2016). Low-dose second-generation oral contraceptives are associated with the lowest increased risk of cardiovascular adverse effects. BMJ Evidence-Based Medicine, 21(6), [232]. https://doi.org/10.1136/ebmed-2016-110500

Vancouver

Løkkegaard E. Low-dose second-generation oral contraceptives are associated with the lowest increased risk of cardiovascular adverse effects. BMJ Evidence-Based Medicine. 2016 Dec;21(6). 232. https://doi.org/10.1136/ebmed-2016-110500

Author

Løkkegaard, Ellen. / Low-dose second-generation oral contraceptives are associated with the lowest increased risk of cardiovascular adverse effects. In: BMJ Evidence-Based Medicine. 2016 ; Vol. 21, No. 6.

Bibtex

@article{324b86ab9e9d439d84aed8c757a6d6c7,
title = "Low-dose second-generation oral contraceptives are associated with the lowest increased risk of cardiovascular adverse effects",
keywords = "Journal Article",
author = "Ellen L{\o}kkegaard",
year = "2016",
month = dec,
doi = "10.1136/ebmed-2016-110500",
language = "English",
volume = "21",
journal = "BMJ Evidence-Based Medicine",
issn = "2515-446X",
publisher = "BMJ Publishing Group",
number = "6",

}

RIS

TY - JOUR

T1 - Low-dose second-generation oral contraceptives are associated with the lowest increased risk of cardiovascular adverse effects

AU - Løkkegaard, Ellen

PY - 2016/12

Y1 - 2016/12

KW - Journal Article

U2 - 10.1136/ebmed-2016-110500

DO - 10.1136/ebmed-2016-110500

M3 - Comment/debate

C2 - 27655112

VL - 21

JO - BMJ Evidence-Based Medicine

JF - BMJ Evidence-Based Medicine

SN - 2515-446X

IS - 6

M1 - 232

ER -

ID: 176667887